ConductScience.org, home

Gene · 3351

Drugs25

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

DrugChEMBL IDMechanismActionSource
ALMOTRIPTANCHEMBL1505Serotonin 1b (5-HT1b) receptor agonistAGONISTChEMBL
ALMOTRIPTAN MALATECHEMBL1200521Serotonin 1b (5-HT1b) receptor agonistAGONISTChEMBL
AMISULPRIDECHEMBL243712Serotonin (5-HT) receptor antagonistANTAGONISTChEMBL
DEXFENFLURAMINECHEMBL248702Serotonin (5-HT) receptor agonistAGONISTChEMBL
DEXFENFLURAMINE HYDROCHLORIDECHEMBL1887891Serotonin (5-HT) receptor agonistAGONISTChEMBL
DONITRIPTANCHEMBL1742428Serotonin 1b (5-HT1b) receptor agonistAGONISTChEMBL
ELETRIPTANCHEMBL1510Serotonin 1b (5-HT1b) receptor agonistAGONISTChEMBL
ELETRIPTAN HYDROBROMIDECHEMBL1201003Serotonin 1b (5-HT1b) receptor agonistAGONISTChEMBL
ELZASONANCHEMBL3185463Serotonin 1b (5-HT1b) receptor antagonistANTAGONISTChEMBL
ELZASONAN HYDROCHLORIDECHEMBL3989805Serotonin 1b (5-HT1b) receptor antagonistANTAGONISTChEMBL
ERGOLOIDCHEMBL2364968Serotonin 1b (5-HT1b) receptor agonistAGONISTChEMBL
ERGOLOID MESYLATESCHEMBL2311030Serotonin 1b (5-HT1b) receptor agonistAGONISTChEMBL
FROVATRIPTANCHEMBL1279Serotonin 1b (5-HT1b) receptor agonistAGONISTChEMBL
FROVATRIPTAN SUCCINATECHEMBL2138684Serotonin 1b (5-HT1b) receptor agonistAGONISTChEMBL
GSK163090CHEMBL1631540Serotonin 1b (5-HT1b) receptor antagonistANTAGONISTChEMBL
NARATRIPTANCHEMBL1278Serotonin 1b (5-HT1b) receptor agonistAGONISTChEMBL
NARATRIPTAN HYDROCHLORIDECHEMBL1200601Serotonin 1b (5-HT1b) receptor agonistAGONISTChEMBL
RIZATRIPTANCHEMBL905Serotonin 1b (5-HT1b) receptor agonistAGONISTChEMBL
RIZATRIPTAN BENZOATECHEMBL1201032Serotonin 1b (5-HT1b) receptor agonistAGONISTChEMBL
SUMATRIPTANCHEMBL128Serotonin 1b (5-HT1b) receptor agonistAGONISTChEMBL

gene-search-2026-11-11-0.2.0

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/genes/v1/3351/drugs